$31.46
1.55% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US80706P1030
Symbol
SRRK

Scholar Rock Holding Corp. Stock price

$31.46
-5.98 15.97% 1M
-5.57 15.04% 6M
-11.76 27.21% YTD
+21.98 231.86% 1Y
+21.24 207.83% 3Y
+18.67 145.97% 5Y
+15.96 102.97% 10Y
+15.96 102.97% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.50 1.55%
ISIN
US80706P1030
Symbol
SRRK
Industry

Key metrics

Basic
Market capitalization
$3.0b
Enterprise Value
$2.7b
Net debt
positive
Cash
$364.4m
Shares outstanding
94.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | 567.4
EV/Sales
- | 509.3
EV/FCF
negative
P/B
9.7
Financial Health
Equity Ratio
77.6%
Return on Equity
-66.8%
ROCE
-73.2%
ROIC
-
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$0.0 | $5.4m
EBITDA
$-269.0m | $-315.2m
EBIT
$-270.7m | $-315.9m
Net Income
$-264.2m | $-256.6m
Free Cash Flow
$-230.2m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-44.2% | -26.0%
EBIT
-43.1% | -25.3%
Net Income
-44.1% | -4.2%
Free Cash Flow
-51.4%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -5,821.6%
EBIT
-
Net
- | -4,740.2%
Free Cash Flow
-
More
EPS
$-2.4
FCF per Share
$-2.4
Short interest
26.4%
Employees
128
Rev per Employee
$0.0
Show more

Is Scholar Rock Holding Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Scholar Rock Holding Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Scholar Rock Holding Corp. forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a Scholar Rock Holding Corp. forecast:

Buy
94%
Hold
6%

Financial data from Scholar Rock Holding Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 81 81
49% 49%
-
- Research and Development Expense 190 190
41% 41%
-
-269 -269
44% 44%
-
- Depreciation and Amortization 1.73 1.73
36% 36%
-
EBIT (Operating Income) EBIT -271 -271
43% 43%
-
Net Profit -264 -264
44% 44%
-

In millions USD.

Don't miss a Thing! We will send you all news about Scholar Rock Holding Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Scholar Rock Holding Corp. Stock News

Neutral
Seeking Alpha
5 days ago
Scholar Rock Holding Corporation (NASDAQ:SRRK ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Akshay K. Vaishnaw - President of R&D, Member of Scientific Advisory Board and Director David L.
Negative
The Motley Fool
5 days ago
It didn't take a high-powered academic to figure out why Scholar Rock's (SRRK -5.99%) share price swooned by more than 5% on Wednesday. That morning, the biotech published a quarterly earnings report and business update that fell short of expectations.
Positive
The Motley Fool
5 days ago
Scholar Rock (SRRK -6.39%), a late-stage biopharmaceutical company specializing in therapies for serious neuromuscular and rare diseases, released its second quarter 2025 earnings on August 6, 2025. The key news was continued preparation for the potential 2025 U.S. launch of apitegromab, its lead muscle-targeted therapy for spinal muscular atrophy (SMA).
More Scholar Rock Holding Corp. News

Company Profile

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Head office United States
CEO David Hallal
Employees 128
Founded 2012
Website scholarrock.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today